Pharmaceutical Quality Control Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The global Pharmaceutical Quality Control market size was estimated at USD 4.2 billion in 2022 and is projected to reach USD 9.64 billion in 2030 at a CAGR of 11.2% during the forecast period 2023-2030.

Pharmaceutical quality control is the integration of all processes to ensure the identity and purity of a particular pharmaceutical product. The global pharmaceutical quality control market is growing rapidly due to the growing awareness of pharmaceutical quality control. Increasing development of comprehensive analytical tests is driving the growth of the market. Demand for integrated analytical services covering all stages of drug research, development and manufacturing also continues to drive the market growth. In addition, the growing demand for pharmaceutical quality control due to the global outbreak of the novel coronavirus disease (COVID-19) presents an opportunity for the market. Technical issues are the major factors restraining the growth of the pharmaceutical quality control market. However, complex and time-consuming regulatory guidelines pose challenges to the growth of the pharmaceutical quality control market.

Another important reason behind the growth of the pharmaceutical quality control market is the increasing technological innovations and advancements offered by the various currently-established market players. They focus on constantly updating technology to improve the quality of care for different patients Pharmaceutical companies are strictly regulated because the health and well-being of consumers is directly affected by drugs, medical devices and other pharmaceutical products. To sell their products, manufacturers must meet several quality criteria. Small and medium pharmaceutical companies are focusing on complying with the law to produce better products and stay competitive in the market due to the rapid expansion of the pharmaceutical industry. The Food and Drug Administration (FDA) regulates the US market, where the majority of companies operating in developing countries like China and India ship their goods. FDA also inspects the facilities and operations of all pharmaceutical manufacturing operations in the United States. such as the overseas operations of companies that regularly sell their products in the United States.

Therefore, these facilities and their processes must comply with current FDA Good Manufacturing Practices (cGMP). To manufacture and market their products, companies must also comply with the International Organization for Standardization (ISO), 21 CFR Part 211, and the ICH Q10 guidelines. Manufacturers are eager to adopt quality management systems due to the increasing importance of regulatory requirements and market expansion. Coronavirus disease has had a significant impact on the growth of the Pharmaceutical Quality Control market. The epidemic has increased the demand for safe and sterile items. Therefore, pharmaceutical companies are now focusing more on the production of high quality products. In addition, significant player growth and investment has driven the Pharmaceutical Quality Control market value. 

Delvens Industry Expert's Standpoint

The pharmaceutical quality control market is a growing number of accredited clinical laboratories, an increasing acceptance of third-party quality control, and an increasing preference for support outside in the quality assessment. The number of laboratory tests performed has increased due to the increasing prevalence of various diseases around the world. Both the public and private sectors are increasing the number of laboratories to meet this requirement. Clinical laboratories must be accredited by regulatory bodies such as the International Organization for Standardization and other equivalent standards to perform diagnostic tests in the majority of countries. Competent authorities evaluate the laboratory's capacity and quality system against predetermined standards during the accreditation process, thereby generating revenue from the pharmaceutical quality control market.

Market Portfolio

Key Findings

• Pharmaceutical Quality Control market segmentation, based on product, including consumables, instruments, and services. The consumer goods segment will dominate the market by 2022. The main auxiliary materials used in production are consumables. Consumables can be divided into three categories things that don't affect quality, things that do and things that affect directly. According to forecasts, the service sector will experience the fastest expansion. Furthermore, the highest market share for pharmaceutical quality and control is in the instrument sector. 

• Pharmaceutical quality control market segmentation based on analysis type including sterility testing, microbial contamination testing, endotoxin testing, stability testing, extraction and filtration testing, raw materials raw and others. Bacterial adulteration test segment dominates the market in 2022. Anaerobic counting test, aerobic count test, mold count test, in vitro test, spore count test, endotoxin test factor, LAL and others are the different categories into which bioburden tests are divided. The bacterial population in a sample was analyzed by an aerobic count assay. It helps to show the quality and degree of damage of the product. Wound cultures, also known as anaerobic counting tests, are performed without the use of oxygen. 
   
• The Pharmaceutical Quality Control market segmentation, based on Products Tested, includes Vaccines, Plasma Product, and Drugs. Vaccines segment dominated the pharmaceutical quality control market in 2022. Finding essential choices for quality control and vaccine production is really important. The sub-segment for drugs is predicted to increase at the quickest rate overall.
   
• By region, the study provides market insights across North America, Europe, Asia-Pacific, and Rest of the World. The pharmaceutical quality control market in North America leads it by 2022 (45.80%). This is due to the evolving healthcare systems in the United States and Canada, the presence of many large manufacturers of molecular quality control products in the region, and access to advanced technologies. in the area. Furthermore, the US pharmaceutical quality control market holds the largest share, and the Canadian pharmaceutical quality control market is the fastest growing market in the North American region. 

Regional Analysis

North America to Dominate the Market

• North America is expected to witness significant growth in the pharmaceutical quality management software market during the forecast period due to factors such as growing demand for management standards. improved production and quality management as well as the increasing adoption of innovative technologies, cloud-based solutions and QMS software in the pharmaceutical industry. 

Competitive Landscape

• Merck KGaA,
• BioMérieux SA,
• Charles River Laboratories International, Inc.,
• Sartorious AG,
• WuXi AppTec,
• Thermo Fisher Scientific, Inc.,
• SGS S.A.,
• Eurofins Scientific,
• Toxikon Corporation,
• McKinsey & Company,
• Esco Micro Pte. Ltd,
• Lucideon Limited,
• PerkinElmer Inc.,
• SOLVIAS AG,
• Shimadzu Scientific Instruments,
• METTLER TOLEDO,
• REMI GROUP,
• BRAM-COR SPA,
• Panomex Inc.,
• Waters Corporation

Recent Developments

• January 2023: Palantir Technologies Inc. launched a consistent quality management system to help life science customers using the Foundry platform meet GxP requirements. 
   
• December 2022: FILTEC, an in-line inspection solutions provider, has launched a new Remote Visual Inspection (RVI) system, a compact and flexible machine vision solution for inspection. 

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
   
• Gain authentic and granular data access for the Pharmaceutical Quality Control Market to understand the trends and the factors involved in changing market situations.
   
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
   
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope